반응식
[CH3:1][N:2]1[C:7](=[O:8])[C:6]2[CH:9]=[CH:10][S:11][C:5]=2[N:4]([CH:12]([CH3:14])[CH3:13])[C:3]1=[O:15].[CH:16]([C:18]1[N:22]([CH3:23])[C:21]2[CH:24]=[CH:25][CH:26]=[CH:27][C:20]=2[N:19]=1)=[O:17]>>[OH:17][CH:16]([C:10]1[S:11][C:5]2[N:4]([CH:12]([CH3:13])[CH3:14])[C:3](=[O:15])[N:2]([CH3:1])[C:7](=[O:8])[C:6]=2[CH:9]=1)[C:18]1[N:22]([CH3:23])[C:21]2[CH:24]=[CH:25][CH:26]=[CH:27][C:20]=2[N:19]=1참가 물질
3
실험 절차
Prepared from 3-Methyl-1-(1-methylethyl)thieno[2,3-d]pyrimidine-2,4(1H, 3H)-dione and 2-formyl-1-methylbenzimidazole following the method of Example 1 step d.
출처 및 근거
- ORD 기록
- ord-67239acb5a1c4f8a921d21eb6f63d953
- 출처 데이터셋
- uspto-grants-2001_10
- 특허 번호
- US06300334B1
연결된 노트
불러오는 중…